gvtcx

Replacement Rotor-Gene Platforms

Public Health England Published 18 Nov 2016 Contracts Finder

key details

Value£65,000
Statuscomplete
Category (CPV) 50800000
Deadline7 Dec 2015
Contract start7 Dec 2015
Contract end7 Dec 2016
SME suitableNo
OCIDocds-b5fd17-1dfb3074-adc9-11e6-9901-0019b9f3037b

Award

SupplierValueDateStatus
Qiagen Ltd £65,000 10 Dec 2015 active

description

The East of England molecular unit based in Cambridge relies on a fleet of rotor-gene platforms to run the vast majority of molecular assays. The total number of these instruments in the Cambridge lab stands at 13 but 3 are of a now obsolete model. The PHE Capital group have approved funding to replace these instruments.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 Dec 2015 Award (award) · ocds-b5fd17-1dfb3074-adc9-11e6-9901-0019b9f3037b-82578-ecm_3401

more from Public Health England

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.